Ethical and moral issues rule out the use of human induced pluripotent stem cells (iPSCs) in chimera studies that would determine the full extent of their reprogrammed state, instead relying on less rigorous assays such as teratoma formation and differentiated cell types. To date, only mouse iPSC lines are known to be truly pluripotent. However, initial mouse iPSC lines failed to form chimeric offspring, but did generate teratomas and differentiated embryoid bodies, and thus these specific iPSC lines were not completely reprogrammed or truly pluripotent. Therefore, there is a need to address whether the reprogramming factors and process used eventually to generate chimeric mice are universal and sufficient to generate reprogrammed iPSC that contribute to chimeric offspring in additional species. Here we show that porcine mesenchymal stem cells transduced with 6 human reprogramming factors (POU5F1, SOX2, NANOG, KLF4, LIN28, and C-MYC) injected into preimplantation-stage embryos contributed to multiple tissue types spanning all 3 germ layers in 8 of 10 fetuses. The chimerism rate was high, 85.3% or 29 of 34 live offspring were chimeras based on skin and tail biopsies harvested from 2- to 5-day-old pigs. The creation of pluripotent porcine iPSCs capable of generating chimeric offspring introduces numerous opportunities to study the facets significantly affecting cell therapies, genetic engineering, and other aspects of stem cell and developmental biology.
Get full access to this article
View all access options for this article.
References
1.
EvansMJ, KaufmanMH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292:154–156.
2.
MartinGR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA, 78:7634–7638.
3.
ThomsonJA, KalishmanJ, GolosTG, DurningM, HarrisCP, BeckerRA, HearnJP. 1995. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA, 92:7844–7848.
4.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS, JonesJM. 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
5.
StrojekRM, ReedMA, HooverJL, WagnerTE. 1990. A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts. Theriogenology, 33:901–913.
6.
LiM, ZhangD, HouY, JiaoL, ZhengX, WangWH. 2003. Isolation and culture of embryonic stem cells from porcine blastocysts. Mol Reprod Dev, 65:429–434.
7.
BlombergLA, SchreierLL, TalbotNC. 2008. Expression analysis of pluripotency factors in the undifferentiated porcine inner cell mass and epiblast during in vitro culture. Mol Reprod Dev, 75:450–463.
8.
PiedrahitaJA, AndersonGB, BondurantRH. 1990. On the isolation of embryonic stem cells: comparative behavior of murine, porcine and ovine embryos. Theriogenology, 34:879–901.
9.
MitalipovaM, BeyhanZ, FirstNL. 2001. Pluripotency of bovine embryonic cell line derived from precompacting embryos. Cloning, 3:59–67.
10.
TakahashiK, YamanakaS. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
11.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
12.
WernigM, MeissnerA, ForemanR, BrambrinkT, KuM, HochedlingerK, BernsteinBE, JaenischR. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448:318–324.
GressensP, DingleyJ, PlaisantF, PorterH, SchwendimannL, VerneyC, TooleyJ, ThoresenM. 2008. Analysis of neuronal, glial, endothelial, axonal and apoptotic markers following moderate therapeutic hypothermia and anesthesia in the developing piglet brain. Brain Pathol, 18:10–20.
16.
XiS, YinW, WangZ, KusunokiM, LianX, KoikeT, FanJ, ZhangQ. 2004. A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Pathol, 85:223–231.
17.
KoopmansSJ, MrozZ, DekkerR, CorbijnH, AckermansM, SauerweinH. 2006. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model. Metabolism, 55:960–971.
18.
BanzY, HessOM, RobsonSC, CsizmadiaE, MettlerD, MeierP, HaeberliA, ShawS, SmithRA, RiebenR. 2007. Attenuation of myocardial reperfusion injury in pigs by mirococept, a membrane-targeted complement inhibitor derived from human CR1. Cardiovasc Res, 76:482–493.
19.
BoschP, PrattSL, SticeSL. 2006. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod, 74:46–57.
20.
DobrinskyJR, PurselVG, LongCR, JohnsonLA. 2000. Birth of piglets after transfer of embryos cryopreserved by cytoskeletal stabilization and vitrification. Biol Reprod, 62:564–570.
21.
MaY, RamezaniA, LewisR, HawleyRG, ThomsonJA. 2003. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells, 21:111–117.
22.
PfeiferA, IkawaM, DaynY, VermaIM. 2002. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA, 99:2140–2145.
EzashiT, TeluguBP, AlexenkoAP, SachdevS, SinhaS, RobertsRM. 2009. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci USA, 106:10993–10998.
25.
WuZ, ChenJ, RenJ, BaoL, LiaoJ, CuiC, RaoL, LiH, GuY, DaiH, ZhuH, TengX, ChengL, XiaoL. 2009. Generation of pig-induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol, 1:46–54.
26.
VodickaP, SmetanaKJr., DvorankovaB, EmerickT, XuYZ, OurednikJ, OurednikV, MotlikJ. 2005. The miniature pig as an animal model in biomedical research. Ann NY Acad Sci, 1049:161–171.
27.
MatsunariH, NagashimaH. 2009. Application of genetically modified and cloned pigs in translational research. J Reprod Dev, 55:225–230.
28.
KekarainenT, SegalesJ. 2009. Torque teno virus infection in the pig and its potential role as a model of human infection. Vet J, 180:163–168.
29.
NiblockMM, LuceCJ, BelliveauRA, PatersonDS, KellyML, SleeperLA, FilianoJJ, KinneyHC. 2005. Comparative anatomical assessment of the piglet as a model for the developing human medullary serotonergic system. Brain Res Brain Res Rev, 50:169–183.
KobayashiM, TakadaT, TakahashiK, NodaY, ToriiR. 2008. BMP4 induces primitive endoderm but not trophectoderm in monkey embryonic stem cells. Cloning Stem Cells, 10:495–502.
32.
NagyA, GoczaE, DiazEM, PrideauxVR, IvanyiE, MarkkulaM, RossantJ. 1990. Embryonic stem cells alone are able to support fetal development in the mouse. Development, 110:815–821.
Schenke-LaylandK, AngelisE, RhodesKE, Heydarkhan-HagvallS, MikkolaHK, MaclellanWR. 2007. Collagen IV induces trophoectoderm differentiation of mouse embryonic stem cells. Stem Cells, 25:1529–1538.
35.
TolkunovaE, CavaleriF, EckardtS, ReinboldR, ChristensonLK, ScholerHR, TomilinA. 2006. The caudal-related protein cdx2 promotes trophoblast differentiation of mouse embryonic stem cells. Stem Cells, 24:139–144.
36.
HembergerM, NozakiT, WinterhagerE, YamamotoH, NakagamaH, KamadaN, SuzukiH, OhtaT, OhkiM, MasutaniM, CrossJC. 2003. Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev Biol, 257:371–381.
37.
HeS, PantD, SchiffmacherA, MeeceA, KeeferCL. 2008. Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells, 26:842–9.
38.
RandJH, WuXX, AndreeHA, LockwoodCJ, GullerS, ScherJ, HarpelPC. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism. N Engl J Med, 337:154–160.
39.
LevineRJ, LamC, QianC, YuKF, MaynardSE, SachsBP, SibaiBM, EpsteinFH, RomeroR, ThadhaniR, KarumanchiSA. 2006. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 355:992–1005.
40.
LangbeinM, StrickR, StrisselPL, VogtN, ParschH, BeckmannMW, SchildRL. 2008. Impaired cytotrophoblast cell-cell fusion is associated with reduced syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev, 75:175–183.
41.
LiaoJ, CuiC, ChenS, RenJ, ChenJ, GaoY, LiH, JiaN, ChengL, XiaoH, XiaoL. 2009. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell, 4:11–15.
42.
WernigM, ZhaoJP, PruszakJ, HedlundE, FuD, SoldnerF, BroccoliV, Constantine-PatonM, IsacsonO, JaenischR. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA, 105:5856–5861.
ParkIH, ZhaoR, WestJA, YabuuchiA, HuoH, InceTA, LerouPH, LenschMW, DaleyGQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141–146.
Wislet-GendebienS, HansG, LeprinceP, RigoJM, MoonenG, RogisterB. 2005. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells, 23:392–402.
47.
FuL, ZhuL, HuangY, LeeTD, FormanSJ, ShihCC. 2008. Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev, 17:1109–1121.
48.
KeeneCD, Ortiz-GonzalezXR, JiangY, LargaespadaDA, VerfaillieCM, LowWC. 2003. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant, 12:201–213.
49.
RiekstinaU, CakstinaI, ParfejevsV, HoogduijnM, JankovskisG, MuiznieksI, MucenieceR, AncansJ. 2009. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev, 5:378–386.
50.
RocheS, RichardMJ, FavrotMC. 2007. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem, 101:271–280.
51.
ChenZ, XuWR, QianH, ZhuW, BuXF, WangS, YanYM, MaoF, GuHB, CaoHL, XuXJ. 2009. Oct4, a novel marker for human gastric cancer. J Surg Oncol, 99:414–419.
52.
RappUR, KornC, CeteciF, KarremanC, LuetkenhausK, SerafinV, ZanuccoE, CastroI, PotapenkoT. 2009. MYC is a metastasis gene for non-small-cell lung cancer. PLoS ONE, 4:e6029.
53.
EzehUI, TurekPJ, ReijoRA, ClarkAT. 2005. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer, 104:2255–2265.
54.
HartAH, HartleyL, ParkerK, IbrahimM, LooijengaLH, PauchnikM, ChowCW, RobbL. 2005. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer, 104:2092–2098.
55.
WernigM, MeissnerA, CassadyJP, JaenischR. 2008. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell, 2:10–12.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
